HER2/neu Receptor Antagonist drugs compared
Compare all 2 HER2/neu Receptor Antagonist drugs side by side, used for conditions such as breast neoplasms, gastrointestinal neoplasms, stomach neoplasms. They share one FDA-defined mechanism but differ in approved uses, prescription status, brand-vs-generic options, price, and FDA recall-safety record — which our independent rating scores. The highest-rated is herceptin.
Top-rated HER2/neu receptor antagonist: 1. Herceptin · 2. Hercessi
| Drug | Generic | Form | Status | Used for | Safety ratingFDA recall-based | Pharmacy pays |
|---|---|---|---|---|---|---|
| Herceptin | Trastuzumab | Injectable | Prescription | Breast Neoplasms, Gastrointestinal Neoplasms | 70/100 | — |
| Hercessi | Trastuzumab-Strf | Injectable | Prescription | Breast Neoplasms, Gastrointestinal Neoplasms | 70/100 | — |
The safety rating column is unique to pharmaranks — an independent 0–100 score from FDA regulatory recall data. Higher is safer. Not medical advice.
Best HER2/neu receptor antagonist by condition
Full ranking · 2 drugs
Frequently asked questions
What is the HER2/neu Receptor Antagonist drug class?
HER2/neu Receptor Antagonist is an FDA Established Pharmacologic Class (EPC) — a group of drugs that share a mechanism of action. pharmaranks lists 2 HER2/neu Receptor Antagonist products, each independently rated.
Are all HER2/neu Receptor Antagonist drugs the same?
No. HER2/neu Receptor Antagonist drugs share the same core mechanism — that is why they sit in one FDA class — but they differ in their approved uses, available forms, whether they are prescription or over-the-counter, brand-vs-generic options and price, and their FDA recall-safety record.
What conditions do HER2/neu Receptor Antagonist drugs treat?
Per NIH RxClass drug-classification data, HER2/neu Receptor Antagonist drugs are used for conditions including breast neoplasms, gastrointestinal neoplasms, stomach neoplasms.
Which HER2/neu Receptor Antagonist drug is best-rated?
By our independent rating, herceptin currently ranks highest among HER2/neu Receptor Antagonist drugs. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
Sources: the HER2/neu Receptor Antagonist class definition and its member drugs come from the U.S. NLM RxClass (Established Pharmacologic Class). Ratings are pharmaranks’ independent FDA recall-safety analysis.